July 30, 2019 / 5:09 AM / 24 days ago

Fresenius Medical Care confirms 2019 targets

(Reuters) - German dialysis specialist Fresenius Medical Care (FMEG.DE) reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

The company confirmed its full-year guidance and still expects sales to rise by 3% to 7%, and adjusted net income change to be in the range of -2% to 2%, after second-quarter revenue came in broadly in line with analysts’ expectations in a Refinitiv poll.

Reporting by Bartosz Dabrowski in Gdynia; Editing by Tomasz Janowski

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below